Delivery Order SPE2DB24D1205-SPE2DB25FDAAG
- Not listed
- The Defense Logistics Agency awarded a $10,858.52 delivery order to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 ml auto-injector pharmaceutical product on July 25, 2025, with final delivery scheduled for July 28, 2025. This firm fixed-price, non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that...
- The Defense Logistics Agency awarded a delivery order valued at $43,770.93 to AmerisourceBergen Drug Corp for the supply of BIMZELX 320 mg/2 mL auto-injector units. The contract, which was competitively awarded without set-aside restrictions, carries a firm fixed price structure and an ultimate completion date of August 18, 2025. Performance of this delivery order will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $69,112.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injectors, with an ultimate completion date of August 5, 2025. This competitive award, which was not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The product will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $11,394.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml auto-injector product, with an ultimate completion date of August 6, 2025. This competitively awarded contract, with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of BIMZELX 320 mg/2 ml auto-injector units valued at $9,855.21 with completion by August 1, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $27,466.85 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjectors. This firm fixed-price, competitively awarded contract was executed on May 27, 2025, with an ultimate completion date of May 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $74,689.95 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/mL auto-injector supplies. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 1, 2025, and performance location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal military and veteran healthcare systems through the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $60,638.45 for BIMZELX 160 mg/mL auto-injector medication. Awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, this firm fixed price delivery order was competitively awarded with no set-aside designation. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- The Defense Logistics Agency awarded a $23,855.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for BIMZELX 320 mg/2 mL auto-injector pharmaceutical product on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,250.68 to AmerisourceBergen Drug Corp for BIMZELX 160 mg/ml autoinjector on August 29, 2025, with completion expected by September 2, 2025. This competitively awarded, firm fixed-price contract involves pharmaceutical delivery to support federal medical procurement needs. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDAAGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $32,307.88 to AmerisourceBergen Drug Corp for BIMZELX 320 MG/2 ML auto-injector pharmaceutical supplies. This firm fixed-price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical vendor supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad portfolio of pharmaceutical products and medical supplies to support military healthcare systems globally, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. AmerisourceBergen's consistent success in winning competitively awarded delivery orders demonstrates its capability to efficiently fulfill diverse federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.3k | 9/2/25 |